Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Nyxoah SA has announced the release date for its first quarter financial results for 2026, set for May 12, 2026. The company, known for its innovative solutions for Obstructive Sleep Apnea (OSA), will host a conference call following the release. Nyxoah’s lead product, the Genio system, is designed for the treatment of OSA and has received various regulatory approvals in Europe and the US. The call aims to discuss the financial performance and future expectations of the company.